Clinical Scientist
Alexion
Clinical Scientist
Alexion
Global biopharmaceuticals focusing on rare diseases
Principal Responsibilities
Contribute to the TA strategy through researching the medical environment, identifying and building relationships with KEEs, and through the planning, preparation of advisory board meetings.
Participate in program meetings to stay updated on the latest progress and provide expert opinions as needed to support team discussion and decision-making.
Act as a point of contact for global clinical development expert
Review and provide expert input on program related documents (e.g. protocol, IB)
Review and/or provide expert input on documents for regulatory interactions (e.g. briefing document for PMDA, Orphan drug designation application)
Review and provide expert input on relevant parts of filing documents (e.g. CTD, J-PI, RMP).
Prepare responses to clinical part of PMDA inquiries in collaboration with JPTL and other JPT members.
Contribute to discussion of PADG team in collaboration with JPTL and medical affairs.
Review and expert input on publication strategy and contents/quality of publications.
(In case of a Japan stand-alone study) create study documents (e.g. protocol concept sheet)
Qualifications
Minimum of eight (8) years of experience in drug development in pharmaceuticals, biopharmaceuticals, or biotechnology.
Experience in Phases 1 to 3 as a clinical scientist.
(Preferred) Experience working in a global pharmaceutical company
Extensive experience as a clinical scientist including KEEs engagement, AdB meetings, preparation of clinical documents (e.g. protocol, IB), regulatory interactions, filing preparation and post-filing inquiry resolution.
Knowledge of local regulations and guidances
English skills that enables communication with global team.
Education
Life Science related bachelor’s degree
Others
Business Trip Available; Visit to mainly domestic medical institutions/doctors, domestic conferences, etc.
Date Posted
13-7月-2026Closing Date
11-7月-2027Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion